E2A deficiency leads to abnormalities in αβ T-cell development and to rapid development of T-cell lymphomas

Molecular and Cellular Biology

Volumn 17, Issue 8, 1997, Pages 4782-4791

  Bain, Gretchen ^a   Engel, Isaac ^a   Maandag, Els C Robanus ^b   Te Riele, Hein P J ^b   Voland, Joseph R ^a   Sharp, Leslie L ^a   Chun, Jerold ^c   Huey, Bing ^d   Pinkel, Dan ^d   Murre, Cornelis ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c San Diego   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; HELIX LOOP HELIX PROTEIN; TRANSCRIPTION FACTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CHROMOSOME 15; CONTROLLED STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; ONCOGENE C MYC; PHENOTYPE; PRIORITY JOURNAL; T CELL LYMPHOMA; T LYMPHOCYTE ACTIVATION; THYMOMA;

ANIMALIA;

EID: 0030752361     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.17.8.4782     Document Type: Article

References (59)

1. Aronheim. A., R. Shiran, A. Rosen, and M. D. Walker. 1993. The E2A gene product contains two separable and functionally distinct transcription activation domains. Proc. Natl. Acad. Sci. USA 90:8063-8067.
2. Bain, G., and I. Engel. Unpublished results.
3. Bain, G., S. Gruenwald, and C. Murre. 1993. E2A and E2-2 are subunits of B-cell-specific E2-box DNA-binding proteins. Mol. Cell. Biol. 13:3522-3529.
4. Bain, G., E. Robanus Maandag, D. Izon, D. Armsen, A. Kruisbeek, B. C. Weintraub, I. Krop, M. S. Schlissel, A. Feeney, M. van Roon, M. van der Valk, H. P. J. te Riele, A. Berns, and C. Murre. 1994. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79:885-892.
5. Bain, G., E. C. Robanus Maandag, H. P. J. te Riele, A. J. Feeney, A. Sheehy, M. Schlissel, S. A. Shinton, R. R. Hardy, and C. Murre. 1997. Both E12 and E47 allow commitment to the B cell lineage. Immunity 6:145-154.
6. Bain, G. Unpublished results.
7. Begley, C. G., P. D. Aplan, S. M. Denning, F. Haynes, T. A. Wadman, and I. R. Kirsch. 1989. The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related motif. Proc. Natl. Acad. Sci. USA 86:10128-10132.
8. Bernard, O., P. Guglielmi, P. Jonveaux, D. Cherif, S. Gisselbrecht, M. Mauchauffe, R. Berger, C. J. Larsen, and D. Mathieu-Mahul. 1990. Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T-cell leukemias. Genes Chromosomes Cancer 1:194-208.
9. Brady, H., and A. Berns. Unpublished results.
10. Chakraborty, T., T. J. Brennan, L. Li, D. Edmondson, and E. Olson. 1991. Inefficient homooligomerization contributes to the dependence of myogenin on E2A products for efficient DNA binding. Mol. Cell. Biol. 11:3633-3641.
11. Chen, Q., J. Cheng, L. Tsai, N. Buchanan, G. Schneider, A. Carroll, W. Crist, B. Ozanne, M. Siciliano, and R. Baer. 1990. The tal-gene undergoes chromosomal translocation in T-cell leukemia and potentially encodes a helix-loop-helix protein. EMBO J. 9:415-424.
12. Davis, R. L., P. F. Cheng, A. B. Lassar, and H. Weintraub. 1990. The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation. Cell 60:733-746.
13. Duncan, D. D., M. Adlam, and G. Siu. 1996. Asymmetric redundancy in CD4 silencer function. Immunity 4:301-311.
14. Godfrey, D. I., J. Kennedy, P. Mombaerts, S. Tonegawa, and A. Zlotnik. 1994. Onset of TCR-beta gene rearrangement and role of TCR-beta expression during CD3-CD4-CD8-thymocyte differentiation. J. Immunol. 152: 4783-4792.
15. Grabstein, K. H., T. J. Waldschmidt, F. D. Finkelman, B. W. Hess, A. R. Alpert, N. E. Boiani, A. E. Namen, and P. J. Morrissey. 1993. Inhibition of murine B and T lymphopoiesis in vivo by an anti-interleukin 7 monoclonal antibody. J. Exp. Med. 178:257.
16. Hardy, R. R., C. E. Carmack, S. A. Shinton, J. D. Kemp, and K. Hayakawa. 1991. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse development. J. Exp. Med. 173:1213-1225.
17. Henthorn, P., M. Kiledjian, and T. Kadesch. 1990. Two distinct transcription factors that bind the immunoglobulin enhancer μE5/kE2 motif. Science 247:467-470.
18. Herman, A., J. W. Kappler, P. Marrack, and A. M. Pullen. 1991. Superantigens: mechanism of T cell stimulation and role in immune responses. Annu. Rev. Immunol. 9:745-772.
19. Hoffman, E. S., L. Passoni, T. Crompton, T. M. Leu, D. G. Schatz, A. Koff, M. J. Owen, and A. C. Hayday. 1996. Productive T-cell receptor beta-chain gene rearrangement: coincident regulation of cell cycle and clonality during development in vivo. Genes Dev. 10:948-962.
20. Hsu, H. L., J. T. Cheng, Q. Chen, and R. Baer. 1991. Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins. Mol. Cell. Biol. 14:1256-1265.
21. Hsu, H., I. Wadman, J. L. Tsan, and R. Baer. 1994. Positive and negative transcriptional control by the TAL1 helix-loop-helix protein. Proc. Natl. Acad. Sci. USA 91:5947-5951.
22. Kallioniemi, A., O.-P. Kallioniemi, D. Sudar, D. Rutovitz, J. W. Gray, F. Waldman, and D. Pinkel. 1992. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821.
23. Lassar, A. B., J. N. Buskin, D. Lockshnn, R. L. Davis, S. Apone, S. D. Hauschka, and H. Weintraub. 1989. MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer. Cell 58:823-831.
24. Lassar, A. B., R. L. Davis, W. E. Wright, T. Kadeseh, C. Murre, A. Voronova, D. Baltimore, and H. Weintraub. 1991. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell 66:305-315.
25. Mallick, C., E. C. Dudley, J. L. Viney, M. J. Owen, and A. C. Hayday. 1993. Rearrangement and diversity of T cell receptor beta chain genes in thymocytes: a critical role for the beta chain in development. Cell 73:513-519.
26. Marcu, K. B., L. J. Harris, L. W. Stanton, J. Erikson, R. Watt, and C. M. Croce. 1983. Transcriptionally active c-myc oncogene is contained within NIARD, a DNA sequence associated with chromosome translocations in B-cell neoplasia. Proc. Natl. Acad. Sci. USA 80:519-523.
27. Massari, M. E., P. Jennings, and C. Murre. 1996. The AD1 transactivation domain of E2A contains a highly conserved helix which is required for its activity in both Succharomyces cerevisiae and mammalian cells. Mol. Cell. Biol. 16:121-129.
28. Melletin, J. D., S. D. Smith, and M. L. Cleary. 1989. lyl-1, a novel gene altered by chromosomal translocation in T cell lymphomas, codes for a protein with a helix-loop-helix DNA binding motif. Cell 58:77-84.
29. Meyer, K. B., M. Skogberg, C. Margenfeld, J. Ireland, and S. Pettersson. 1995. Repression of the immunoglobulin heavy chain 3′ enhancer by helix-loop-helix protein Id3 via a functionally important E47/E12 binding site: implications for developmental control of enhancer function. Eur. J. Immunol. 25:1770-1777.
30. Miyamoto, A., X. Cui, L. Naumovski, and M. L. Cleary. 1996. Helix-loop-helix proteins LYL-1 and E2A form heterodimeric complexes with distinctive DNA binding properties in hematolymphoid cells. Mol. Cell. Biol. 16: 2344-2401.
31. Mombaerts, P., A. R. Clarke, M. A. Rudnicki, J. Iacomini, S. Ilohara, J. J. Lafaille, L. Wang, Y. Ichikawa, R. Jaenisch, M. L. Hooper, and S. Tonegawa. 1992. Mutations in T-cell antigen receptor genes α and β block thymocyte development at different developmental stages. Nature 360:225-231.
32. Mombaerts, P., J. Iacomini, R. S. Johnson, K. Herrup, S. Tonegawa, and V. E. Papaioannou. 1992. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68:869-877.
33. Murre, C., P. S. McCaw, and D. Baltimore. 1989. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 56:777-783.
34. Murre, C., P. S. McCaw, H. Vaessin, M. Caudy, L. Y. Jan, Y. N. Jan, C. V. Cabrera, J. N. Buskin, S. D. Hauschka, A. B. Lassar, H. Weintraub, and D. Baltimore. 1989. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58:537-544.
35. Murre, C., A. Voronova, and D. Baltimore. 1991. B-cell- and myocyte-specific E2-box-binding factors contain E12/E47-like subunits. Mol. Cell. Biol. 11: 1156-1160.
36. Peers, B., J. Leonard, S. Sharma, G. Teitelman, and M. R. Montminy. 1994. Insulin expression in pancreatic islet cells relies on cooperative interactions between the helix-loop-helix factor E47 and the homeohox factor STF-1. Mol. Endocrinol. 8:1798-1806.
37. Penit, C., B. Lucas, and F. Vasseur. 1995. Cell expansion and growth arrest phases during the transition from precursor (CD4-8-) to immature (CD4+8+) thymocytes in normal and genetically modified mice. J. Immunol. 154:5103-5113.
38. Piper, J., D. Rutovitz, D. Sudar, A. Kallioniemi, O.-P. Kallioniemi, F. M. Waldman, J. W. Gray, and D. Pinkel. 1995. Computer image analysis of comparative genomic hybridization. Cytometry 19:10-26.
39. Pongubala, J., and M. Atchison. 1991. Functional characterization of the developmentally controlled immunoglobulin kappa 3′ enhancer: regulation by Id, a repressor of helix-loop-helix transcription factors. Mol. Cell. Biol. 11:1040-1047.
40. Quong, M. W., M. E. Massari, R. Zwart, and C. Murre. 1993. A new transcriptional activation motif restricted to a class of helix-loop-helix proteins is functionally conserved in both yeast and mammalian cells. Mol. Cell. Biol. 13:792-800.
41. Roberts, V. J., R. Steenbergen, and C. Murre. 1993. Localization of E2A mRNA expression in developing and adult rat tissues. Proc. Natl. Acad. Sci. USA 90:7583-7587.
42. Rolink, A., E. ten Boekel, F. Melchers, D. T. Fearon, I. Krop, and J. Andersson. 1996. A subpopulation of B220 + cells in murine bone marrow does not express CD19 and contains natural killer cell progenitors. J. Exp. Med. 183:187-194.
43. Sawada, S., and D. R. Littman. 1993. A heterodimer of HEB and an E12-related protein interacts with the CD4 enhancer and regulates its activity in T-cell lines. Mol. Cell. Biol. 13:5620-5628.
44. Shen, C. P., and T. Kadesch. 1995. B-cell-specific DNA binding by an E47 homodimer. Mol. Cell. Biol. 15:4518-4524.
45. Shinkai, Y., G. Rathbun, K.-P. Lam, E. M. Oltz, V. Stewart, M. Mendelsohn, J. Charron, M. Datta, F. Young, A. M. Stall, and F. W. Alt. 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68:855-867.
46. Stewart, M., E. Cameron, M. Campbell, R. McFarlane, S. Toth, K. Lang, D. Onions, and J. C. Neil. 1993. Conditional expression and oncogenicity of c-myc linked to a CD2 gene dominant control region. Int. J. Cancer 53:1023-1030.
47. Sun, X. H., and D. Baltimore. 1991. An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers. Cell 64:459-470.
48. Sun, X. H. 1994. Constitutive expression of the Id1 gene impairs mouse B cell development. Cell 79:893-901.
49. Takeda, J., A. Cheng, F. Mauxion, C. A. Nelson, R. D. Newberry, W. C. Sha, R. Sen, and D. Y. Loh. 1990. Functional analysis of the murine T-cell receptor β enhancer and characteristics of its DNA-binding proteins. Mol. Cell. Biol. 10:5027-5035.
50. von Boehmer, H. 1990. Developmental biology of T cells in T cell-receptor transgenic mice. Annu. Rev. Immunol. 8:531-556.
51. Voronova, A. F., and D. Baltimore. 1990. Mutations that disrupt DNA binding and dimer formation in the E47 helix-loop-helix protein map to distinct domains. Proc. Natl. Acad. Sci. USA 87:4722-4726.
52. Voronova, A. F., and F. Lee. 1994. The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin-6 induced myeloid differentiation. Proc. Natl. Acad. Sci. USA 91:5952-5956.
53. Whelan, J., S. R. Cordle, E. Henderson, P. A. Weil, and R. Stein. 1990. Identification of a pancreatic β-cell insulin gene transcription factor that binds to and appears to activate cell-type-specific gene expression: its possible relationship to other cellular factors that bind to a common insulin gene sequence. Mol. Cell. Biol. 10:1564-1572.
54. Wilson, A., A. D'Amico, T. Ewing, R. Scollay, and K. Shortman. 1988. Subpopulations of early thymocytes. A cross-correlation flow cytometric analysis of adult mouse Ly-2-L3T4-(CD8-CD4-) thymocytes using eight different surface markers. J. Immunol. 140:1461-1470.
55. Xia, Y., L. Brown, C. Y. C. Yang, J. T. Tsan, M. J. Siciliano, I. Espinosas, M. M. LeBeau, and R. Baer. 1991. TAL-2, a helix-loop-helix gene activated by the (7;9)(q34;32) translocation in human T-cell lymphoma. Proc. Natl. Acad. Sci. USA 88:11416-11420.
56. Xia, Y., L. Y. Hwang, M. H. Cobb, and R. Baer. 1994. Products of the tal2 oncogene in leukemic T cells: bHLH phosphoproteins with DNA-binding activity. Oncogene 9:1437-1446.
57. Zhuang, Y., P. Soriano, and H. Weintraub. 1994. The helix-loop-helix gene E2A is required for B cell formation. Cell 79:875-885.
58. Zuniga-Pflucker, J. C., D. Jiang, and M. J. Lenardo. 1995. Requirement for TNF-α and IL-1α in fetal thymocyte commitment and differentiation. Science 268:1906-1909.
59. Zuniga-Pflucker, J. C., and M. Lenardo. 1996. Regulation of thymocyte development from immature progenitors. Curr. Opin. Immunol. 8:215-224.